RecallDepth
Class I Terminated

Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, packaged in a) 30-count Unit of Use bottles (NDC 0008-0836-21) UPC 3 0008-0836-21 7; b) 90-count Unit of Use bottles (NDC 0008-0836-22) UPC 3 0008-0836-22 4; Rx only, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA 19101.

This recall has been terminated (originally issued May 28, 2014).

Company
Pfizer Us Pharmaceutical Group
Recall Initiated
March 6, 2014
Posted
May 28, 2014
Recall Number
D-1328-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
49,847 bottles
Firm Location
New York, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: a) V130142, Exp 10/15; b) V130140, Exp 10/15

More recalls by Pfizer Us Pharmaceutical Group

View all recalls by this company →

Other recent Class I Drug recalls